StockData
ITGRNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Integer Holdings Corp

Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 4, 2026
$126.75+0.05 (+0.04%)

Close on Oct 19, 2026

Market cap
$4.33B
P/E (TTM)
34.6
Dividend yield
–

Integer Holdings Corp revenue by segment

By business segment

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
Medical––––––––$1.63B$1.60B$1.55B$1.51B––
Non-Medical––––––––$34.30M$36.41M$43.33M$49.89M––
Operating incomeTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23YoY
Medical––––––––$299.97M$287.06M$269.51M$254.96M–
Non-Medical––––––––-$315.00K-$545.00K$3.18M$6.86M–

By product or service

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
Cardio & Vascular$1.10B$1.11B$1.11B$1.08B$1.04B$986.60M$949.58M$916.92M$889.92M–$836.34M–59.9%+5.9%
Cardiac Rhythm Management & Neuromodulation$678.44M$676.72M$668.80M$672.02M$667.96M$664.02M$660.61M$643.33M$638.36M–$612.89M–36.8%+1.6%
Other Markets$61.61M$69.16M$77.75M$80.88M$84.81M$95.57M$106.41M–––––3.3%-27.4%

By region

From the segment and revenue-disaggregation notes of Integer's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.